The effect of levamisole on experimental gingivitis in juvenile periodontitis. Sequential clinical, immunological, and haematological changes.
D000251:Adenosine Triphosphatases / Q000097:blood; D000328:Adult; D000942:Antigens, Bacterial; D001402:B-Lymphocytes / Q000276:immunology; D002464:Cell Migration Inhibition; D003165:Complement System Proteins / Q000032:analysis; D003773:Dental Plaque / Q000382:microbiology; D004341:Drug Evaluation; D005891:Gingivitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D007978:Levamisole / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000201:enzymology; D008875:Middle Aged; D010518:Periodontitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D013601:T-Lymphocytes / Q000276:immunology
D000942:Antigens, Bacterial; D007136:Immunoglobulins; D007978:Levamisole; D003165:Complement System Proteins; D000251:Adenosine Triphosphatases